Zibold J, Lessard L, Picard F, da Silva L, Zadorozhna Y, Streichenberger N, et al. The new missense G376V-TDP-43 variant induces late-onset distal myopathy but not amyotrophic lateral sclerosis. Brain. 2023;: pubmed publisher

Abayev Avraham M, Salzberg Y, Gliksberg D, Oren Suissa M, Rosenzweig R. DNAJB6 mutants display toxic gain of function through unregulated interaction with Hsp70 chaperones. Nat Commun. 2023;14:7066 pubmed publisher

Riemenschneider H, Simonetti F, Sheth U, Katona E, Roth S, Hutten S, et al. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo. Acta Neuropathol Commun. 2023;11:112 pubmed publisher

P xe9 rez Berlanga M, Wiersma V, Zbinden A, De Vos L, Wagner U, Foglieni C, et al. Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns. EMBO J. 2023;:e111719 pubmed publisher

Ervilha Pereira P, Schuermans N, Meylemans A, LeBlanc P, Versluys L, Copley K, et al. C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD. Acta Neuropathol. 2023;145:793-814 pubmed publisher

Shen H, Yanas A, Owens M, Zhang C, Fritsch C, Fare C, et al. Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation. Mol Cell. 2022;: pubmed publisher

Peinado J, Chaplot K, Jarvela T, Barbieri E, Shorter J, Lindberg I. Sequestration of TDP-43216-414 Aggregates by Cytoplasmic Expression of the proSAAS Chaperone. ACS Chem Neurosci. 2022;13:1651-1665 pubmed publisher

Ma X, Prudencio M, Koike Y, Vatsavayai S, Kim G, Harbinski F, et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. 2022;603:124-130 pubmed publisher

Hallegger M, Chakrabarti A, Lee F, Lee B, Amalietti A, Odeh H, et al. TDP-43 condensation properties specify its RNA-binding and regulatory repertoire. Cell. 2021;184:4680-4696.e22 pubmed publisher

Hutten S, Usluer S, Bourgeois B, Simonetti F, Odeh H, Fare C, et al. Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions. Cell Rep. 2020;33:108538 pubmed publisher

Perdikari T, Murthy A, Ryan V, Watters S, Naik M, Fawzi N. SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs. EMBO J. 2020;:e106478 pubmed publisher

Babinchak W, Dumm B, Venus S, Boyko S, Putnam A, Jankowsky E, et al. Small molecules as potent biphasic modulators of protein liquid-liquid phase separation. Nat Commun. 2020;11:5574 pubmed publisher

Perdikari T, Murthy A, Ryan V, Watters S, Naik M, Fawzi N. SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins. bioRxiv. 2020;: pubmed publisher

Mann J, Gleixner A, Mauna J, Gomes E, DeChellis Marks M, Needham P, et al. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019;102:321-338.e8 pubmed publisher

McGurk L, Gomes E, Guo L, Mojsilovic Petrovic J, Tran V, Kalb R, et al. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Mol Cell. 2018;71:703-717.e9 pubmed publisher

Wang A, Conicella A, Schmidt H, Martin E, Rhoads S, Reeb A, et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37: pubmed publisher